Emily Vance

408 total citations
18 papers, 299 citations indexed

About

Emily Vance is a scholar working on Ophthalmology, Immunology and Epidemiology. According to data from OpenAlex, Emily Vance has authored 18 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 9 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Emily Vance's work include Ocular Diseases and Behçet’s Syndrome (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Emily Vance is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Emily Vance collaborates with scholars based in United States, Australia and Japan. Emily Vance's co-authors include Holly L. Rosenzweig, James T. Rosenbaum, Ellen J Lee, Paige Snow, Stephen R. Planck, Michael P. Davey, Justine R. Smith, Rachel R Caspi, Christine A. Wells and Xin Lin and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Emily Vance

16 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Vance United States 11 128 78 72 58 53 18 299
Mukadder Koçak Türkiye 10 46 0.4× 58 0.7× 18 0.3× 33 0.6× 84 1.6× 29 349
Ferda Artüz Türkiye 12 98 0.8× 34 0.4× 34 0.5× 13 0.2× 118 2.2× 54 404
Nurdan Lenk Türkiye 10 38 0.3× 27 0.3× 36 0.5× 29 0.5× 63 1.2× 15 279
Joshua Sciurba United States 9 109 0.9× 74 0.9× 41 0.6× 41 0.7× 80 1.5× 11 319
Jasper H. Kappen Netherlands 13 89 0.7× 58 0.7× 441 6.1× 104 1.8× 23 0.4× 28 704
Dawn M. Cleaver United States 8 45 0.4× 26 0.3× 33 0.5× 81 1.4× 36 0.7× 8 326
M Satoh Japan 10 71 0.6× 93 1.2× 68 0.9× 133 2.3× 63 1.2× 19 421
Orfanos Ce Germany 11 102 0.8× 77 1.0× 15 0.2× 18 0.3× 37 0.7× 45 337
Eric T. Cole United States 8 256 2.0× 213 2.7× 94 1.3× 45 0.8× 53 1.0× 8 533
Anand Rajpara United States 9 56 0.4× 37 0.5× 27 0.4× 17 0.3× 96 1.8× 78 284

Countries citing papers authored by Emily Vance

Since Specialization
Citations

This map shows the geographic impact of Emily Vance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Vance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Vance more than expected).

Fields of papers citing papers by Emily Vance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Vance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Vance. The network helps show where Emily Vance may publish in the future.

Co-authorship network of co-authors of Emily Vance

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Vance. A scholar is included among the top collaborators of Emily Vance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Vance. Emily Vance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rosenzweig, Holly L., Emily Vance, Ellen J Lee, et al.. (2023). Card9/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis. Annals of the Rheumatic Diseases. 83(2). 214–222. 14 indexed citations
2.
Lee, Ellen J, Ruth J. Napier, Emily Vance, et al.. (2022). The innate immune receptor Nlrp12 suppresses autoimmunity to the retina. Journal of Neuroinflammation. 19(1). 69–69. 7 indexed citations
3.
Lee, Ellen J, et al.. (2022). T cell intrinsic Nod2 controls Th17 immunity to Candida albicans infection. The Journal of Immunology. 208(Supplement_1). 58.08–58.08.
4.
Napier, Ruth J., Emily Vance, Ellen J Lee, & Holly L. Rosenzweig. (2021). Card9 promotes pathogenic neutrophil responses that induce Th17-mediated autoimmune arthritis and spondylitis. The Journal of Immunology. 206(1_Supplement). 60.11–60.11. 1 indexed citations
5.
Lee, Ellen J, Emily Vance, Dana J. Philpott, et al.. (2021). Nod2-deficient CD4+ T cells protect against Candida albicans infection. The Journal of Immunology. 206(1_Supplement). 16.20–16.20.
6.
Napier, Ruth J., Ellen J Lee, Michael P. Davey, et al.. (2020). T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis. Nature Communications. 11(1). 5406–5406. 23 indexed citations
7.
Napier, Ruth J., Ellen J Lee, Emily Vance, et al.. (2018). Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis. The Journal of Immunology. 201(7). 1889–1898. 15 indexed citations
8.
Brown, B. R., Paige Snow, Emily Vance, et al.. (2017). Fungal-derived cues promote ocular autoimmunity through a Dectin-2/Card9-mediated mechanism. Clinical & Experimental Immunology. 190(3). 293–303. 23 indexed citations
9.
Lee, Ellen J, Emily Vance, Paige Snow, et al.. (2016). Mincle Activation and the Syk/Card9 Signaling Axis Are Central to the Development of Autoimmune Disease of the Eye. The Journal of Immunology. 196(7). 3148–3158. 53 indexed citations
10.
Vance, Emily, Ellen J Lee, Paige Snow, et al.. (2016). The innate immune receptor Nlrp12 participates in protection against experimental autoimmune uveitis. 57(12). 490–490. 1 indexed citations
11.
Lee, Ellen, Paige Snow, Emily Vance, et al.. (2016). Mincle activation and the Syk/Card9 signaling axis are central to development of autoimmune disease of the eye. The Journal of Immunology. 196(1_Supplement). 48.17–48.17. 1 indexed citations
12.
Lee, Ellen J, et al.. (2015). Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice. Arthritis Research & Therapy. 17(1). 218–218. 10 indexed citations
13.
Lee, Ellen, João M. Furtado, Emily Vance, et al.. (2013). An unexpected role for the innate immune receptor NOD2 in suppression of experimental autoimmune uveitis. Investigative Ophthalmology & Visual Science. 54(15). 2523–2523. 1 indexed citations
14.
Rosenzweig, Holly L., et al.. (2011). NOD2 Deficiency Results in Increased Susceptibility to Peptidoglycan-Induced Uveitis in Mice. Investigative Ophthalmology & Visual Science. 52(7). 4106–4106. 20 indexed citations
16.
Rosenbaum, James T., Sirichai Pasadhika, Elliott D. Crouser, et al.. (2009). Hypothesis: Sarcoidosis is a STAT1-mediated disease. Clinical Immunology. 132(2). 174–183. 70 indexed citations
17.
Chaw, R. Crystal, Emily Vance, & Steven D. Black. (2007). Gastrulation in the spider Zygiella x‐notata involves three distinct phases of cell internalization. Developmental Dynamics. 236(12). 3484–3495. 18 indexed citations
18.
Auwaerter, Paul G., David Oldach, M. L. Warner, et al.. (1996). Community-Acquired Pneumonia. Infectious Diseases in Clinical Practice. 5(3). 189–190. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026